Johnson & Johnson never has made much of a mark in the sphere of early drug development. But now J&J (
$JNJ) is thinking globally and acting locally, creating a plan to become a more prominent player in the field of translational medicine by setting up deal teams in four biotech hotspots around the world.
About US
Contact us
